These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23776774)

  • 21. Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program.
    Mudzviti T; Sibanda M; Gavi S; Maponga CC; Morse GD
    J Infect Dev Ctries; 2012 Nov; 6(11):806-8. PubMed ID: 23277506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Antifungal Therapy: Emerging Culprits of Cutaneous Adverse Drug Reactions.
    Chaudhary RG; Rathod SP; Jagati A; Zankat D; Brar AK; Mahadevia B
    Indian Dermatol Online J; 2019; 10(2):125-130. PubMed ID: 30984585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
    Wang F; Zhao YK; Li M; Zhu Z; Zhang X
    Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
    Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
    Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Epidemiological and Clinical Analysis of Cutaneous Adverse Drug Reactions Seen in a Tertiary Care Outpatient Clinic in Cairo, Egypt.
    El-Nabarawy EA; Elmasry MF; El Lawindi MI; Tarek YA
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):233-242. PubMed ID: 30390725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Study of Cutaneous Adverse Drug Reactions and their Association with Autoimmune Diseases at a Tertiary Centre in South-West Rajasthan, India.
    Rana S; Gupta K; Agarwal N; Ahamed ANM
    Indian J Dermatol; 2021; 66(4):445. PubMed ID: 34759420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous adverse drug reactions with fixed-dose combinations: Special reference to self-medication and preventability.
    Tripathy R; Pattnaik KP; Dehury S; Patro S; Mohanty P; Sahoo SS; Mohanty S
    Indian J Pharmacol; 2018; 50(4):192-196. PubMed ID: 30505055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous drug reactions in children: a multicentric study.
    Dilek N; Özkol HU; Akbaş A; Kılınç F; Dilek AR; Saral Y; Metin A; Çalka Ö
    Postepy Dermatol Alergol; 2014 Dec; 31(6):368-71. PubMed ID: 25610351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annular erythema and photosensitivity as manifestations of efavirenz-induced cutaneous reactions: a review of five consecutive cases.
    Isaacs T; Ngwanya MR; Dlamini S; Lehloenya RJ
    J Antimicrob Chemother; 2013 Dec; 68(12):2871-4. PubMed ID: 23852540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
    Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
    Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
    Latha S; Choon SE
    Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Boonyagars L; Hirunwiwatkul P; Hurst CP
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
    Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
    Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.
    Greil W; Zhang X; Stassen H; Grohmann R; Bridler R; Hasler G; Toto S; Bleich S; Kasper S
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):111-121. PubMed ID: 30424913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions profile of antimicrobials: A 3-year experience, from a tertiary care teaching hospital of India.
    ; Tandon VR; Sharma S; Khajuria V; Mahajan V; Gillani Z
    Indian J Med Microbiol; 2015; 33(3):393-400. PubMed ID: 26068342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of Cutaneous Adverse Reactions to Levetiracetam and Human Leukocyte Antigen Typing in North-Indian Patients.
    Ramanujam B; Ihtisham K; Kaur G; Srivastava S; Mehra NK; Khanna N; Singh M; Tripathi M
    J Epilepsy Res; 2016 Dec; 6(2):87-92. PubMed ID: 28101480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending Tertiary Care Hospital.
    Doshi K; Yegnanarayan R; Gokhale N
    Curr Drug Saf; 2016 Jul; ():. PubMed ID: 27457767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
    Mushiroda T; Takahashi Y; Onuma T; Yamamoto Y; Kamei T; Hoshida T; Takeuchi K; Otsuka K; Okazaki M; Watanabe M; Kanemoto K; Oshima T; Watanabe A; Minami S; Saito K; Tanii H; Shimo Y; Hara M; Saitoh S; Kinoshita T; Kato M; Yamada N; Akamatsu N; Fukuchi T; Ishida S; Yasumoto S; Takahashi A; Ozeki T; Furuta T; Saito Y; Izumida N; Kano Y; Shiohara T; Kubo M;
    JAMA Neurol; 2018 Jul; 75(7):842-849. PubMed ID: 29610831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.